Skip to content

The Clinical and Prognostic Features of PRES

The Features of Clinical Imaging, Disease Severity and Pregnancy Outcomes in Posterior Reversible Encephalopathy Syndrome With Preeclampsia or Eclampsia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05143710
Enrollment
354
Registered
2021-12-03
Start date
2020-10-01
Completion date
2022-01-31
Last updated
2022-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eclampsia, Posterior Reversible Encephalopathy Syndrome, Preeclampsia, Pregnancy Outcomes

Brief summary

The purpose of this study is to determine the features of clinical imaging, disease severity and pregnancy outcomes in posterior reversible encephalopathy syndrome with preeclampsia or eclampsia.

Detailed description

The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES with preeclampsia or eclampsia to analyze features of clinical imaging, disease severity and pregnancy outcomes during 2012 to 2021.Then, the investigators grouped all the patients into early onset group and late onset PE group according to gestational weeks to analyze differences of clinical imaging. Finally, the investigators grouped all the patients into good pregnancy outcomes group and poor pregnancy outcomes group according to diagnostic criteria, including the incidence of stillbirth and premature birth, to analyze differences of clinical imaging .

Interventions

DIAGNOSTIC_TESTPRES in PE or E

patients diagnosed with posterior reversible encephalopathy syndrome with preeclampsia or eclampsia

Sponsors

Dunjin Chen
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. patients were diagnosed of PRES with PE or E 2. all patients provided written informed consent

Exclusion criteria

1. patients combined with other neurological disorders 2. patients combined with mental illness

Design outcomes

Primary

MeasureTime frameDescription
features of clinical imagingCranial Imaging was examined immediately at the onset of symptoms, such as s headaches, visual changes, seizures, consciousness impairment, mental disorders, and focal neurological deficits.The imaging features were described by their location including frontal, parietal, occipital, temporal, cerebellum, basal ganglia, brain stem, deep white matter and callosum, and 1 point was recorded for each location involved.
blood pressure(BP)The BP of patients was obtained immediately at the onset of symptoms.hypertension:≥140/90mmHg
biochemical parametersBiochemical indicators were collected within 1 week of the hospital stay.The PRES patients may have a lower level of serum albumin (﹤35g/L) ,and have a higher level of lactic dehydrogenase (﹥380U/L).
pregnancy outcomesThe pregnancy outcomes will record immediately when the patients deliver.The rates of stillbirth and premature birth (gestation less than 37 weeks) in PRES patients.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026